This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xoph [2020/07/08 18:45] rkoebnik [XopH] |
bacteria:t3e:xoph [2020/10/28 12:20] (current) rkoebnik [XopH] |
||
---|---|---|---|
Line 2: | Line 2: | ||
Author: Isabel Rodrigues\\ | Author: Isabel Rodrigues\\ | ||
- | Internal reviewer: | + | Internal reviewer: |
Expert reviewer: FIXME | Expert reviewer: FIXME | ||
Line 9: | Line 9: | ||
Prototype: XopH (// | Prototype: XopH (// | ||
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
- | 3D structure: [[https:// | + | Synonym: AvrBs1.1\\ |
+ | 3D structure: [[https:// | ||
===== Biological function ===== | ===== Biological function ===== | ||
Line 15: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurenn | + | The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was first reported in 1988 (Ronald and Staskawicz 1988) and discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurlebeck |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) //in vitro// and //in vivo// and enhanced disease symptoms (Blüher //et al//., 2017). | + | The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) |
=== Regulation === | === Regulation === | ||
Line 40: | Line 41: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes (//e.g. Xanthomonas campestris pv. campestris// | + | Yes (//e.g. Xanthomonas campestris pv. campestris// |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Line 49: | Line 50: | ||
Blüher D, Laha D, Thieme S, Hofer A, Eschen-Lippold L, Masch A, Balcke G, Pavlovic I, Nagel O, Schonsky A, Hinkelmann R, Wörner J, Parvin N, Greiner R, Weber S, Tissier A, Schutkowski M, Lee J, Jessen H, Schaaf G, Bonas U (2017). A 1-phytase type III effector interferes with plant hormone signaling. Nat. Commun. 8: 2159. DOI: [[http:// | Blüher D, Laha D, Thieme S, Hofer A, Eschen-Lippold L, Masch A, Balcke G, Pavlovic I, Nagel O, Schonsky A, Hinkelmann R, Wörner J, Parvin N, Greiner R, Weber S, Tissier A, Schutkowski M, Lee J, Jessen H, Schaaf G, Bonas U (2017). A 1-phytase type III effector interferes with plant hormone signaling. Nat. Commun. 8: 2159. DOI: [[http:// | ||
- | Gurenn | + | Gurlebeck |
+ | |||
+ | Hajri A, Pothier JF, Fischer-Le Saux M, Bonneau S, Poussier S, Boureau T, Duffy B, Manceau C (2011). Type three effector gene distribution and sequence analysis provide new insights into the pathogenicity of plant-pathogenic // | ||
Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | ||
- | Potnis N, Minsavage G, Smith J K, Hurlbert J C, Norman D, Rodrigues R, Stall R E, Jones JB (2012). Avirulence proteins AvrBs7 from // | + | Potnis N, Minsavage G, Smith J K, Hurlbert J C, Norman D, Rodrigues R, Stall R E, Jones JB (2012). Avirulence proteins AvrBs7 from // |
+ | |||
+ | Ronald PC, Staskawicz BJ (1988). The avirulence gene AVrBs1 from // | ||
+ | |||
+ | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
- | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | + | White FF, Jones JB (2018). One effector at a time. Nature Plants 4: 134-135. DOI: [[https://www.nature.com/articles/ |
===== Further reading ===== | ===== Further reading ===== |